Post-remission therapy with allogeneic stem cell transplantation from an HILA-matched family donor in younger patients with acute myeloid leukaemia exhibiting a normal karyotype:: differential effects of molecular markers

被引：0
|
作者：
Schlenk, RF
Corbacioglu, A
Krauter, J
Fröhling, S
Bunjes, D
Späth, D
Schäfer, I
Döhner, H
Ganser, A
Döhner, K
机构：
[1] Univ Ulm, Ulm, Germany
[2] Hannover Med Sch, D-3000 Hannover, Germany
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [11] Post-Remission Treatment with Allogeneic Stem Cell Transplantation Improves Outcome in Patients Aged 60 Years and Older with Acute Myeloid Leukemia in First Remission
    Versluis, Jurjen
    Hazenberg, Carin L. E.
    van Putten, Wim
    Passweg, Jakob R.
    Maertens, Johan
    Biemond, Bart J.
    Schouten, Harry C.
    Pabst, Thomas
    Lowenberg, Bob
    Ossenkoppele, Gert J.
    Vellenga, Edo
    Cornelissen, Jan J.
    BLOOD, 2014, 124 (21)
  • [12] Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.
    Pfeiffer, Tim
    Schleuning, Michael
    Eder, Matthias
    Tischer, Johanna
    Braess, Jan
    Bunjes, Donald W.
    Greinix, Hildegard
    Bug, Gesine
    Holler, Ernst
    Oruzio, Daniel V.
    Krejci, Marta
    Scheid, Christof
    Gerbitz, Armin
    Kolbe, Karin
    Meyer, Ralf G.
    Arnold, Renate
    Christopeit, Maximilian
    Baurmann, Herrad
    von Harsdorf, Stephanie
    Bethge, Wolfgang Andreas
    Dammann, Elke
    Rothmayer, Margarete
    Franke, Anne
    Schnittger, Susanne
    Mayer, Jiri
    Schlimok, Guenther
    Schwerdtfeger, Rainer
    Ganser, Arnold
    Kolb, Hans Jochem
    Schmid, Christoph
    BLOOD, 2009, 114 (22) : 497 - 497
  • [13] Superiority of autologous over allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after intensive chemotherapy
    Thomas, X
    Le, QH
    Fenaux, P
    Dombret, H
    Chelghoum, Y
    Pautas, C
    Dreyfus, F
    Stamatoullas, A
    Dhedin, N
    Troncy, J
    Pigneux, A
    Thiebaut, A
    Elhamri, M
    Michallet, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S172 - S172
  • [14] Clinical perspectives on post-induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation
    Sweet, Kendra
    Cluzeau, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2025, 206 (01) : 61 - 68
  • [15] The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Over Chemotherapy As Post-Remission Treatment for Patients with High-Risk Acute Lymphoblastic Leukemia in First Remission
    Hu, Jiong
    Dou, Han-Bo
    Wang, Ling
    Tang, Wei
    BLOOD, 2012, 120 (21)
  • [16] Impact of molecular markers on long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia patients
    Michallet, M.
    Sobh, M.
    Thomas, X.
    Charlot, C.
    Barraco, F.
    Cannas, G.
    Nicolini, F. E.
    Nicolas-Virelizier, E.
    Plesa, C.
    Chelghoum, Y.
    Troncy, J.
    Magaud, J. -P.
    Tigaud, I.
    Hayette, S.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S92 - S92
  • [17] Effective post-remission therapy with an autologous stem cell transplant (ASCT) for the ELN-favourable and intermediate-risk acute myeloid leukaemia (AML) patients
    Cerny, J.
    Ramanathan, M.
    Raffel, G.
    Evens, A.
    Walsh, W.
    Fortier, N.
    Shanahan, L.
    Bednarik, J.
    Rosmarin, A.
    Nath, R.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S538 - S539
  • [18] Randomized clinical trial for study of post-remission consolidation chemotherapy effect before allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia in Shariati Hematology Oncology and Stem cell Transplantation Center in 2008-2012
    Ghavamzadeh, A.
    Hooghooghi, M.
    Alimoghaddam, K.
    Mousavi, S.
    Bahar, B.
    Iravani, M.
    Jalali, A.
    Jalili, M.
    Sharifi-Aliabadi, L.
    Eini, E.
    Maheriazar, R.
    Jahani, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S399 - S399
  • [19] Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia
    Hsieh, Yao-Yu
    Hong, Ying-Chung
    Hsiao, Liang-Tsai
    Yu, Yuan-Bin
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    Lin, Han-Nan
    Hsu, Yen-Ning
    Chiou, Tzeon-Jye
    Chen, Po-Min
    Tzeng, Cheng-Hwai
    Liu, Chun-Yu
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (03) : 237 - 245
  • [20] High-dose busulfan post-remission therapy in the elderly with acute myeloid leukaemia supported by autologous stem cell transplantation:: long-term follow-up
    Wandt, H.
    Schaefer-Eckart, K.
    Aulitzky, W. E.
    Bornhaeuser, M.
    Ho, A. D.
    Kaesberger, J.
    Peter, N.
    Schmitz, N.
    Wilhelm, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S64 - S64
12345